Adam Jakus, PhD, is the Co-Founder and Chief Technology of Dimension Inx which develops transformative advanced manufacturing materials and processes for medical biofabrications. Adam received his BS and MS degrees in Materials Science and Engineering (MSE) from Georgia Tech and PhD in MSE from Northwestern University (NU). While at NU, Adam developed an entirely new, materials-centric approach to 3D-printing, now referred to as 3D-Painting, and hundreds of new 3D-printable materials. These materials include but are not limited to Hyperelastic Bone® (A surgically friendly, factor- and cell-free, highly osteo-regenerative biomaterial), 3D-Graphene (A highly electrically conductive biomaterial utilized for cardiac, muscular, and neurological tissue repair and regeneration), organ-specific Tissue Papers (A new class of biomaterials derived from individual tissues and organs), and Fluffy-X™ (an advanced, highly porous biomaterial with extensive applications in soft tissue and full organ repair and biofabrication to be used in conjunction with advanced hydrogels), as well as 3D-Metals and Alloys, advanced ceramics for energy storage and generation, electronics, extraterrestrial regoliths, and more. In 2016, Adam co-founded Dimension Inx to commercialize and translate the 3D-Painting technology - developing and manufacturing new advanced materials for 3D-Printing and developing and co-developing clinical products. Adam is the author and co-author of numerous high impact medical and non-medical publications, book chapters, and industrial publications. He is a primary inventor on more than one dozen advanced materials and biofabrication-related patents and patent applications. Adam and his company Dimension Inx are active members of the Advanced Regenerative Manufacturing Institute (ARMI), SMEs Medical Manufacturing Innovations group, and other organizations. As part of these societies, Adam is not only involved with technology development and education, but also activities related to standards development, professional certificates and certifications, biofabrictaion body of knowledge development, and regulatory input and guidelines.